Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.
Ludvigsen M, Campbell AJ, Enemark MB, Hybel TE, Karjalainen-Lindsberg ML, Beiske K, Bjerre M, Pedersen LM, Holte H, Leppä S, Jørgensen JM, Honoré B.
Ludvigsen M, et al. Among authors: karjalainen lindsberg ml.
Blood Cancer J. 2023 Oct 26;13(1):161. doi: 10.1038/s41408-023-00931-6.
Blood Cancer J. 2023.
PMID: 37884514
Free PMC article.
No abstract available.